Interius BioTherapeutics to Present In Vivo CAR Data in Oncology and Autoimmunity Programs at the American Society of Gene and Cell Therapy 27th Annual Meeting
/PRNewswire/ -- Interius BioTherapeutics, a leading developer of in vivo cell-specific gene medicines, today announced the presentation of preclinical data...
United States Prnewswire Interius Biotherapeutics Phil Johnson Detargeted Vesiculovirus Fusogen American Society Of Gene Analytics Assay Development
Source: prnewswire.com